Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Clinical trial NCT05438498 · TERMINATED

Trial details

NCT number: NCT05438498
Sponsor: MediMergent, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2022-06-03
Primary completion: 2023-04-29
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.